Nicotinamide Supplementation Attenuates Renal Interstitial Fibrosis via Boosting the Activity of Sirtuins
Background: Progressive tubulointerstitial fibrosis (TIF) is the final common pathway leading to ESRD. There is an urgent need to develop effective approaches slowing the progression of TIF. Previous studies showed that systemic supplementation of nicotinamide (NAM) increases renal NAD+ and reverses...
Saved in:
Main Authors: | Xin Zhen (Author), Shaowu Zhang (Author), Feifei Xie (Author), Miaomiao Zhou (Author), Zheng Hu (Author), Fengxin Zhu (Author), Jing Nie (Author) |
---|---|
Format: | Book |
Published: |
Karger Publishers,
2021-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Paclitaxel attenuates renal interstitial fibroblast activation and interstitial fibrosis by inhibiting STAT3 signaling
by: Zhang L, et al.
Published: (2015) -
20 Sirtuin1 inhibitor nicotinamide disrupts HIV-1 latency
by: S. Samer, et al.
Published: (2016) -
Klotho supplementation reverses renal dysfunction and interstitial fibrosis in remnant kidney.
by: Tsuneo Takenaka, et al.
Published: (2023) -
Application of Histone Deacetylase Inhibitors in Renal Interstitial Fibrosis
by: Ling Nie, et al.
Published: (2020) -
Targeting Ferroptosis Attenuates Interstitial Inflammation and Kidney Fibrosis
by: Lu Zhou, et al.
Published: (2021)